Description:
Home Page: www.revbiosciences.com
5 West 21st Street
New York,
NY
10010
United States
Phone:
917 622 5800
Officers
| Name | Title |
|---|---|
| Mr. James M. Rolke | CEO & Director |
| Mr. Chester Stanley Zygmont III | Chief Financial Officer |
| Ms. Sandra Vedrick | VP of HR & Investor Relations |
| Ms. Carol Odle | Sr. Director of Clinical Projects |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2020-11-16 |
| Fiscal Year End: | December |
| Full Time Employees: | 6 |